XBI 250509 82.50C(XBI250509C82500) Stock Price Today

US OptionsDetailed Quotes

XBI250509C82500

Watchlist

1.29
-0.95-42.41%

15min DelayClose May 5 16:00 ET

1.29High1.29Low

Intraday

5D
Daily

News

These Are the Sectors Best Liked Within Defensive and Cyclicals Groups – Morgan Stanley
Seeking AlphaMay 5 10:20 ET
Pfizer Sticks to 2025 Profit View as It Shrugs off Plunging Paxlovid Sales for COVID
MarketWatchApr 29 10:11 ET · Earnings
Trump Reportedly Weighing a Move to Cut U.S. Drug Prices to International Levels
Seeking AlphaApr 22 07:48 ET
US Recession 'Countdown' Has Begun As Trump Tariffs Push Odds To 45%, Goldman Sachs Warns
BenzingaApr 7 08:54 ET
Cantor Analyst rarely criticized the USA Secretary of Health, stating that "misguided decisions will backfire on the government's reputation," causing the Biotechnology Sector to plummet.
The financial services institution Cantor Fitzgerald's Biotechnology Analysts Josh Schimmer and Eric Schmidt rarely publicly criticized the leadership of USA Health Secretary Kennedy.
Zhitong FinanceMar 31 21:09 ET
Heard on the Street: Biotech Investors Rush for the Exits After FDA Official Resigns -- WSJ
WSJMar 31 11:05 ET

Comments

amily

Mar 26 21:49

$Recursion Pharmaceuticals (RXRX.US)$ follow $SPDR S&P Biotech ETF (XBI.US)$

iamiam

Mar 19 20:09

Update, 19 Mar

A big day today, J Powow speaks, and the dots get plotted 😆
I will start with QQQ/ND and VIX, and then I will move to individual stocks. I don't own these and don't necessarily recommend buying them. I use them as sentiment and market bias/direction indicators.
I will be upfront and say my bias is up. How high doesn't really matter to me. I don't own the MAG 7. I just want to see willing buyers. I'm not nieve and am hedged for downside. but I have been buying a lot of individual ...

+33

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?

MyTradeHunter

Mar 19 00:19

Issue #203 - Synthetic Stock on XBI (18.3.25)

Options Trading Newsletter Issue #203 from Substack.
SYNTHETIC Stock ON XBI
The SPDR S&P Biotech ETF (XBI) is an equal-weighted ETF that tracks the S&P Biotechnology Select Industry Index. Unlike market-cap-weighted ETFs, XBI gives equal exposure to small, mid, and large biotech stocks. This makes it more volatile compared to other biotech ETFs like IBB, which is more weighted toward large-cap biotech firms.
XBI Price Action Analysis
– XBI has been on...

74425369

Mar 10 19:40

INSIDER BUY ALERT: JANX

What happened: In recent weeks, $Janux Therapeutics (JANX.US)$ has seen significant insider buying, notably from RA Capital Management, which acquired shares worth approximately $25.3M.
Big picture: Janux's stock has been volatile, trading near its 52-week low. Investor sentiment remains cautious amidst broader biotech sector challenges.
Key Developments:
📊 Positive Clinical Data: JANX007 showed impressive results in Phase 1 trials for metastatic castration-resistant prost...

MyTradeHunter

Mar 6 23:02

Issue #201 - Recycling IWM Strangle

from Substack MyTradeHunter Newsletter
Market Scorecard
Market is weak with NQ dropping more than 7% and ES more by 5%. On contrast HSI has remained strong in anticipation of positive news flows coming out from the CCP Meetings in China, ongoing.
Trade Scorecard
IBIT Call Ratio (Update)
IBIT has hit roller coaster with selloff to a low of $46.07. Price has since recovered to $51.44.
We closed the short call 57C on 27 February when IBIT hit lows of $46.90 for $0...